Target intelligence / Profile preview

Mycobacterial membrane energetics and transport machinery

Molecular classification
Transporter, Enzyme, Electron Transport Chain, Other
01

Overview

The mycobacterial membrane energetics and transport machinery is a complex system of proteins and processes essential for the survival of Mycobacterium tuberculosis (Mtb), especially within the acidic environment of host macrophages (Zhang et al., 2003). This machinery includes the electron transport chain, ATP synthase, and various transporters that collectively maintain the proton motive force (PMF), membrane potential, and internal pH homeostasis (Rao et al., 2008). The first-line anti-tuberculosis drug pyrazinamide (PZA) specifically targets this system in acidic conditions. PZA is converted into pyrazinoic acid (POA) by the bacterial enzyme pyrazinamidase; in acidic environments, POA acts as a protonophore, shuttling protons into the cell and dissipating the PMF (Gygli et al., 2017). This disruption inhibits critical membrane-associated functions, such as nutrient uptake and efflux, and depletes cellular ATP, leading to the death of both actively growing and persistent bacilli. Other drugs, such as bedaquiline and verapamil, also interact with components of this bioenergetic machinery, highlighting its importance as a multi-component therapeutic target (Chen et al., 2018). The system's vulnerability in acidic conditions makes it a unique and vital focus for shortening TB treatment and addressing drug-tolerant persisters.

Other names
Mycobacterial membrane energeticsMycobacterial membrane transport machineryProton motive force maintenance systemPZA target systemMycobacterial bioenergetics
02

Mechanism of action

Disruption of the proton motive force (PMF) and membrane potential, leading to the inhibition of membrane-bound transport systems and energy production, particularly under acidic conditions.

03

Biological functions

Energy transductionIon homeostasispH regulationMembrane transport
04

Disease associations

Infection
05

Safety considerations

HepatotoxicityHyperuricemiaQT prolongationSkin discolorationDrug resistance development
06

Interacting drugs

Pyrazinamide

7 more in the full profile.

07

Biomarkers

pncA mutation statusIntrabacterial pHATP concentration

Beyond the preview

Go deeper on Mycobacterial membrane energetics and transport machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterial membrane energetics and transport machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call